Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Mueller, J. [1 ,2 ,3 ]
Schaedelin, S. [4 ]
Benkert, P. [4 ]
Haenni, P. [5 ]
Schmid, J. [5 ]
Derfuss, T. [1 ,2 ,3 ]
Kuhle, J. [1 ,2 ,3 ]
Yaldizli, O. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Basel, MS Ctr, Neurol Clin & Policlin, Basel, Switzerland
[2] Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci Basel RC2NB, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland
[5] Swiss Federat Common Tasks Hlth Insurances SVK, Solothurn, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P819
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [41] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Hongxiu Luo
    Harsh Bhatt
    Shaza Mohamad
    Eric Uhrik
    Shuvendu Sen
    Teena Mathew
    Abdalla Yousif
    Journal of Neurology, 2015, 262 : 779 - 780
  • [42] Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis
    Srichawla, Bahadar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [43] Diroximel fumarate and dimethyl fumarate demonstrate early clinical and radiological efficacy in relapsing-remitting multiple sclerosis
    Singer, Barry A.
    Shafer, S. James
    Arnold, Douglas L.
    Bowen, James D.
    LaGanke, Christopher
    Chen, Hailu
    Hanna, Jerome
    Miller, Catherine
    Leigh-Pemberton, Richard
    Naismith, Robert T.
    NEUROLOGY, 2020, 94 (15)
  • [44] Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy
    Mantovani, Lorenzo Giovanni
    Cortesi, Paolo Angelo
    Cardillo, Alessandra
    Santoni, Laura
    Prosperini, Luca
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2022, 23 (01) : 13 - 28
  • [45] Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
    D'Amico, Emanuele
    Zanghi, Aurora
    Callari, Graziella
    Borriello, Giovanna
    Gallo, Antonio
    Graziano, Giusi
    Valentino, Paola
    Buccafusca, Maria
    Cottone, Salvatore
    Salemi, Giuseppe
    Ragonese, Paolo
    Bossio, Roberto Bruno
    Docimo, Renato
    Grimaldi, Luigi Maria Edoardo
    Pozzilli, Carlo
    Tedeschi, Gioacchino
    Zappia, Mario
    Patti, Francesco
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [46] Dimethyl Fumarate demonstrates Cost-effectiveness vs Teriflunomide in Treatment-naive Patients with Relapsing-remitting Multiple Sclerosis in Sweden
    Hernandez, L.
    Toro-Diaz, H.
    Cele, C.
    Harrington, A.
    Kinter, E.
    Lundqvist, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 138 - 138
  • [47] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence
    Bayas, Antonios
    Maeurer, Mathias
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 265 - 274
  • [48] Teriflunomide: A guide to its use in relapsing-remitting multiple sclerosis in the EU
    Keating G.M.
    Garnock-Jones K.P.
    Drugs & Therapy Perspectives, 2014, 30 (7) : 241 - 247
  • [49] Dimethyl Fumarate: A Review in Relapsing-Remitting MS
    Hannah A. Blair
    Drugs, 2019, 79 : 1965 - 1976
  • [50] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert
    Phillips, J. Theodore
    Hotermans, Christophe
    Zhang, Annie
    Viglietta, Vissia
    Miller, David
    NEUROLOGY, 2013, 80
12345